Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Damasiewicz

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
JBMR Plus|November 22, 2018
Rethinking Bone Disease in Kidney DiseaseMatthew J Damasiewicz, Thomas L Nickolas
Current Opinion in Nephrology and Hypertension|December 14, 2019
Bisphosphonate therapy in CKD: the current state of affairsMatthew J Damasiewicz, Thomas L Nickolas
Nephrology (Carlton, Vic.)|December 24, 2010
Unilateral upper limb lympatic obstruction and severe lymphoedema in a patient on long-term sirolimusMatthew J Damasiewicz, Francesco L Ierino
Nephrology (Carlton, Vic.)|December 24, 2010
Intra-dialytic hypotension and blood volume and blood temperature monitoringMatthew J Damasiewicz, Kevan R Polkinghorne
Clinical Journal of the American Society of Nephrology : CJASN|March 15, 2015
Is nutritional vitamin D supplementation beneficial in dialysis patients?Matthew J Damasiewicz, Nigel D Toussaint
Kidney360|April 4, 2022
Global Dialysis Perspective: AustraliaMatthew J Damasiewicz, Kevan R Polkinghorne
Nephrology (Carlton, Vic.)|April 22, 2017
Do the benefits of using calcitriol and other vitamin D receptor activators in patients with chronic kidney disease outweigh the harms?Nigel D Toussaint, Matthew J Damasiewicz
Nephrology (Carlton, Vic.)|April 22, 2017
Management of mineral and bone disorders in renal transplant recipientsMatthew J Damasiewicz, Peter R Ebeling
Clinical Nephrology|July 9, 2015
Vitamin D therapy in chronic kidney disease: back to the future?Matthew J Damasiewicz, Peter G Kerr, Kevan R Polkinghorne
Nephrology (Carlton, Vic.)|January 27, 2011
Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implicationsMatthew J Damasiewicz, Nigel D Toussaint, Kevan R Polkinghorne
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
JBMR Plus|November 22, 2018
Rethinking Bone Disease in Kidney DiseaseMatthew J Damasiewicz, Thomas L Nickolas
Current Opinion in Nephrology and Hypertension|December 14, 2019
Bisphosphonate therapy in CKD: the current state of affairsMatthew J Damasiewicz, Thomas L Nickolas
Nephrology (Carlton, Vic.)|December 24, 2010
Unilateral upper limb lympatic obstruction and severe lymphoedema in a patient on long-term sirolimusMatthew J Damasiewicz, Francesco L Ierino
Nephrology (Carlton, Vic.)|December 24, 2010
Intra-dialytic hypotension and blood volume and blood temperature monitoringMatthew J Damasiewicz, Kevan R Polkinghorne
Clinical Journal of the American Society of Nephrology : CJASN|March 15, 2015
Is nutritional vitamin D supplementation beneficial in dialysis patients?Matthew J Damasiewicz, Nigel D Toussaint
Kidney360|April 4, 2022
Global Dialysis Perspective: AustraliaMatthew J Damasiewicz, Kevan R Polkinghorne
Nephrology (Carlton, Vic.)|April 22, 2017
Do the benefits of using calcitriol and other vitamin D receptor activators in patients with chronic kidney disease outweigh the harms?Nigel D Toussaint, Matthew J Damasiewicz
Nephrology (Carlton, Vic.)|April 22, 2017
Management of mineral and bone disorders in renal transplant recipientsMatthew J Damasiewicz, Peter R Ebeling
Clinical Nephrology|July 9, 2015
Vitamin D therapy in chronic kidney disease: back to the future?Matthew J Damasiewicz, Peter G Kerr, Kevan R Polkinghorne
Nephrology (Carlton, Vic.)|January 27, 2011
Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implicationsMatthew J Damasiewicz, Nigel D Toussaint, Kevan R Polkinghorne
Pageof 2